Trial intelligence / Profile preview

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

NCT07149207Phase 2Recruiting

Sponsor
Medical University of South Carolina
Start
May 2026
Primary completion
Apr 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of indocyanine green in head and neck squamous cell carcinoma (HNSCC), sponsored by Medical University of South Carolina. Started May 2026; status: recruiting.

02

Drugs

indocyanine green
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT07149207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07149207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call